CINECA IRIS Institutional Research Information System

LAMBA, SIMONA ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.196
EU - Europa 3.821
AS - Asia 3.280
SA - Sud America 340
OC - Oceania 106
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.862
CN - Cina 1.614
IT - Italia 1.303
DE - Germania 386
GB - Regno Unito 380
JP - Giappone 340
FR - Francia 300
SG - Singapore 293
ES - Italia 184
CA - Canada 183
IE - Irlanda 181
KR - Corea 162
PL - Polonia 157
FI - Finlandia 130
TR - Turchia 125
TW - Taiwan 124
MX - Messico 122
SE - Svezia 116
IN - India 102
UA - Ucraina 88
HK - Hong Kong 86
DK - Danimarca 78
PE - Perù 78
NL - Olanda 77
AU - Australia 75
BR - Brasile 71
CH - Svizzera 65
AT - Austria 64
BE - Belgio 64
ID - Indonesia 61
CO - Colombia 58
VN - Vietnam 56
IL - Israele 55
RO - Romania 52
TH - Thailandia 45
CL - Cile 43
EC - Ecuador 39
PT - Portogallo 33
CZ - Repubblica Ceca 32
NZ - Nuova Zelanda 31
SA - Arabia Saudita 31
IR - Iran 29
AR - Argentina 28
RU - Federazione Russa 24
JO - Giordania 23
GR - Grecia 22
HU - Ungheria 22
NO - Norvegia 17
LB - Libano 16
PH - Filippine 15
MY - Malesia 14
MO - Macao, regione amministrativa speciale della Cina 13
PK - Pakistan 12
PR - Porto Rico 12
KZ - Kazakistan 11
SK - Slovacchia (Repubblica Slovacca) 11
GY - Guiana 10
PS - Palestinian Territory 10
SN - Senegal 10
AE - Emirati Arabi Uniti 9
LV - Lettonia 7
HR - Croazia 6
NI - Nicaragua 6
CY - Cipro 5
EG - Egitto 5
KW - Kuwait 5
MA - Marocco 5
NG - Nigeria 5
QA - Qatar 5
VE - Venezuela 5
BG - Bulgaria 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LT - Lituania 4
TN - Tunisia 4
UY - Uruguay 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
BA - Bosnia-Erzegovina 3
BD - Bangladesh 3
BY - Bielorussia 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
IQ - Iraq 2
MN - Mongolia 2
RS - Serbia 2
SV - El Salvador 2
TZ - Tanzania 2
A1 - Anonimo 1
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
EU - Europa 1
KE - Kenya 1
Totale 12.785
Salva come PNG Salva come JPEG
Città #
Ann Arbor 806
Chandler 287
Beijing 272
Singapore 220
Fairfield 201
Guangzhou 185
Shanghai 170
Dublin 166
Santa Clara 160
Houston 155
Redwood City 153
Turin 139
Ashburn 138
Milan 136
Dearborn 124
Woodbridge 111
Cambridge 100
Seattle 99
Torino 89
Wilmington 82
Tokyo 80
New York 77
Warsaw 65
Lima 62
Pisa 58
Wuhan 58
Villeurbanne 55
Columbus 53
Jacksonville 53
Nyköping 53
Lappeenranta 52
Nanjing 52
Hangzhou 47
Taipei 47
Vienna 47
Boston 46
Fremont 46
Princeton 44
Rome 43
Dundee 41
Paris 40
Barcelona 39
Medford 39
Toronto 39
Naples 38
Berlin 36
Chengdu 36
Istanbul 35
Munich 35
Buffalo 34
Jakarta 34
Los Angeles 34
Boardman 33
San Diego 33
Stuttgart 33
London 31
Carrara 30
Seoul 30
Brussels 28
Ithaca 28
Chicago 27
Washington 26
Baltimore 24
Bogotá 24
Florence 24
Genoa 24
Jinan 24
Zurich 24
Dong Ket 23
Zhengzhou 22
Chongqing 21
Duncan 21
Bangkok 20
Bologna 20
Iowa City 20
Ottawa 20
Santiago 20
Shenyang 20
Toulouse 20
Amman 19
Medellín 19
San Jose 18
Tianjin 18
Central District 17
Jerusalem 17
Luni 17
Marcellus 17
Pittsburgh 17
Sydney 17
Bengaluru 16
Brooklyn 16
Bucharest 16
Rochester 16
Shenzhen 16
Changsha 15
Concepción 15
Frankfurt am Main 15
Xi'an 15
Guadalajara 14
Madrid 14
Totale 6.325
Salva come PNG Salva come JPEG
Nome #
High-dose Vitamin C enhances cancer immunotherapy 4.854
Adaptive mutability of colorectal cancers in response to targeted therapies 1.895
EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer 577
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer 540
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 502
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 383
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 340
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. 288
Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis 248
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 248
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone. 194
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 172
RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells. 168
Mutational profiling of kinases in glioblastoma. 155
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies 138
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer 135
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 132
Absence of AKT1 mutations in glioblastoma 118
Abstract 1163: Microenvironment targets in KRAS-mutated metastatic colorectal cancer 118
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 115
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF 113
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer 112
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. 111
AKT1 (E17K) in human solid tumours 108
Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer 108
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 100
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors 93
Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma 92
Mutational profile of GNAQQ209 in human tumors 77
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 75
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 75
Mutational profiling of Cancer Candidate genes in Glioblastoma, Melanoma and Pancreatic Carcinoma reveals a snapshot of their genomic landscapes 74
Targeted Knock-in of the Polymorphism rs61764370 Does Not Affect KRAS Expression but Reduces let-7 Levels 69
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance 68
The prognostic IDH1 ( R132 ) mutation is associated with reduced NADP (+)-dependent IDH activity in glioblastoma 65
Ras Mutations in Cancer 58
Isogenic K-Ras mutant cancer cells: A novel platform for drug profiling 55
Dual VEGFA/BRAF targeting boosts PD-1 blockade in melanoma through GM-CSF-mediated infiltration of M1 macrophages 37
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 26
Abstract 5900: Tolerance to colibactin correlates with response to chemotherapeutic agents in colorectal cancer 25
Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells 23
Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer 23
Abstract A120: Adaptive mutability of colorectal cancers in response to targeted therapies 22
DNA demethylation triggers cell free DNA release in colorectal cancer cells 21
Abstract B110: Heterogeneous genetic alterations emerge during acquired resistance to anti-EGFR therapy in colorectal cancer 19
Concomitant blockade of EGFR and MEK overcomes acquired resistance to anti-EGFR therapy in colorectal cancer cells and patients’ avatars 19
Abstract C94: Heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer are sensitive to concomitant inhibition of EGFR and MEK 17
Raise and decline of KRAS mutant clones in colorectal cancers (CRCs) treated with multiple rounds of anti-EGFR antibodies 14
Abstract 5723: Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth 12
Abstract 2743: Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer 11
Totale 13.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.200
article - articoli 0
book - libri 0
conference - conferenze 1.986
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020514 0 0 0 0 0 103 100 39 64 74 82 52
2020/20212.077 57 93 203 214 173 192 254 145 183 171 125 267
2021/20222.695 273 270 286 345 180 159 195 199 207 151 234 196
2022/20232.420 159 157 200 188 151 283 237 217 257 158 246 167
2023/20242.301 229 188 217 217 198 169 164 172 74 255 201 217
2024/20251.708 146 210 237 362 503 250 0 0 0 0 0 0
Totale 13.042